Retinol-binding protein 4 as a novel risk factor for cardiovascular disease in patients with coronary artery disease and hyperinsulinemia

American Journal of the Medical Sciences

Volumn 348, Issue 6, 2014, Pages 474-479

  Li, Fei ^a   Xia, Ke ^a,b   Li, Chuanchang ^a   Yang, Tianlun ^a,c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Coronary artery disease; Hyperinsulinemia; Retinol binding protein 4

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; RETINOL BINDING PROTEIN 4; TRIACYLGLYCEROL; URIC ACID; BIOLOGICAL MARKER; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMA RETINOL BINDING PROTEIN; RBP4 PROTEIN, HUMAN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CARDIAC PATIENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSESSMENT; DISEASE ASSOCIATION; FEMALE; HOMEOSTATIC MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROTEIN BLOOD LEVEL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; AGED; BLOOD; CASE CONTROL STUDY; COMPLICATION; HYPERINSULINISM; METABOLISM;

AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYPERINSULINISM; INSULIN RESISTANCE; MALE; MIDDLE AGED; RETINOL-BINDING PROTEINS, PLASMA; RISK FACTORS; TRIGLYCERIDES; URIC ACID;

EID: 84922391364     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0000000000000347     Document Type: Article

References (42)

1. Fu Y, Luo N, Klein RL, et al. Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. J Lipid Res 2005; 46:1369-79.
2. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004;89:2548-56.
3. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004;92:347-55.
4. Yang Q, Graham TE, Mody N, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005;436:356-62.
5. Cho YM, Youn B-S, Lee H, et al. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care 2006;29:2457-61.
6. Graham TE, Yang Q, Bluher M, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006;354:2552-63.
7. Kloeting N, Graham TE, Berndt J, et al. Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab 2007;6:79-87.
8. Ribel-Madsen R, Friedrichsen M, Vaag A, et al. Retinol-binding protein 4 in twins regulatory mechanisms and impact of circulating and tissue expression levels on insulin secretion and action. Diabetes 2009;58:54-60.
9. Stefan N, Schick F, Hennige AM, et al. High circulating retinolbinding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans. Diabetes Care 2007;30:1173-8.
10. Stern MP. Diabetes and cardiovascular disease. The "common soil" hypothesis. Diabetes 1995;44:369-74.
11. Matsumoto K, Miyake S, Yano M, et al. Insulin resistance and arteriosclerosis obliterans in patients with NIDDM. Diabetes Care 1997;20: 1738-43.
12. Hanley AJ, Williams K, Stern MP, et al. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: The San Antonio Heart Study. Diabetes Care 2002;25:1177-84.
13. Bonora E, Formentini G, Calcaterra F, et al. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care 2002;25:1135-41.
14. Mallat Z, Simon T, Benessiano J, et al. Retinol-binding protein 4 and prediction of incident coronary events in healthy men and women. J Clin Endocrinol Metab 2008;94:255-60.
15. Sun Q, Kiernan UA, Shi L, et al. Plasma retinol-binding protein 4 (RBP4) levels and risk of coronary heart disease: A prospective analysis among women in the nurses' health study. Circulation 2013;127:1938-47.
16. Vu-Dac N, Gervois P, Torra IP, et al. Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids. J Clin Invest 1998;102:625-32.
17. Oren A, Vos LE, Uiterwaal CS, et al. Cardiovascular risk factors and increased carotid intima-media thickness in healthy young adults: The Atherosclerosis Risk in Young Adults (ARYA) Study. Arch Intern Med 2003;163:1787-92.
18. Furumoto T, Fujii S, Saito N, et al. Relationships between brachial artery flow mediated dilation and carotid artery intima-media thickness in patients with suspected coronary artery disease. Jpn Heart J 2002;43: 117-25.
19. Park SE, Kim DH, Lee JH, et al. Retinol-binding protein-4 is associated with endothelial dysfunction in adults with newly diagnosed type 2 diabetes mellitus. Atherosclerosis 2009;204:23-5.
20. Xiao Y, Xu A, Hui X, et al. Circulating lipocalin-2 and retinol-binding protein 4 are associated with intima-media thickness and subclinical atherosclerosis in patients with type 2 diabetes. PLoS One 2013;8: e66607.
21. Bobbert T, Raila J, Schwarz F, et al. Relation between retinol, retinolbinding protein 4, transthyretin and carotid intima media thickness. Atherosclerosis 2010;213:549-51.
22. Ingelsson E, Lind L. Circulating retinol-binding protein 4 and subclinical cardiovascular disease in the elderly. Diabetes Care 2009;32: 733-5.
23. Wu J, Shi YH, Niu DM, et al. Association among retinol-binding protein 4, small dense LDL cholesterol and oxidized LDL levels in dyslipidemia subjects. Clin Biochem 2012;45:619-22.
24. von Eynatten M, Lepper PM, Liu D, et al. Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease. Diabetologia 2007;50:1930-7.
25. Ingelsson E, Sundström J, Melhus H, et al. Circulating retinolbinding protein 4, cardiovascular risk factors and prevalent cardiovascular disease in elderly. Atherosclerosis 2009;206:239-44.
26. Cabré A, Lázaro I, Girona J, et al. Retinol-binding protein 4 as a plasma biomarker of renal dysfunction and cardiovascular disease in type 2 diabetes. J Intern Med 2007;262:496-503.
27. Mahmoudi MJ, Mahmoudi M, Siassi F, et al. Circulating retinolbinding protein 4 concentrations in patients with coronary artery disease and patients with type 2 diabetes mellitus. Int J Diabetes Dev Ctries 2012;32:105-10.
28. Radziuk J. Insulin sensitivity and its measurement: structural commonalities among the methods. J Clin Endocrinol Metab 2000;85: 4426-33.
29. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998;21:2191-2.
30. Belfiore F, Iannello S, Volpicelli G. Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels. Mol Genet Metab 1998;63:134-41.
31. Akbay E, Muslu N, Nayir E, et al. Serum retinol binding protein 4 level is related with renal functions in type 2 diabetes. J Endocrinol Invest 2010;33:725-9.
32. Thawnashom K, Tungtrongchitr R, Chanchay S, et al. Association between retinol-binding protein and renal function among Asian subjects with type 2 diabetes mellitus: A cross-sectional study. Southeast Asian J Trop Med Public Health 2011;42:936-45.
33. Polidori MC, Pratico D, Parente B, et al. Elevated lipid peroxidation biomarkers and low antioxidant status in atherosclerotic patients with increased carotid or iliofemoral intima media thickness. J Invest Med 2007;55:163-7.
34. Gey KF, Ducimetiere P, Evans A, et al. Low plasma retinol predicts coronary events in healthy middle-aged men: The PRIME Study. Atherosclerosis 2010;208:270-4.
35. Al-Daghri NM, Al-Attas OS, Alokail M, et al. Retinol binding protein-4 is associated with TNF-alpha and not insulin resistance in subjects with type 2 diabetes mellitus and coronary heart disease. Dis Markers 2009;26:135-40.
36. Lu P, Hu D, Lu J, et al. The association between uric acid and coronary heart disease [in Chinese]. Zhonghua Nei Ke Za Zhi 2002;41:526-9.
37. Ouchi N, Kihara S, Arita Y, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000;102:1296-301.
38. Ouchi N, Kihara S, Arita Y, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001;103:1057-63.
39. Arita Y, Kihara S, Ouchi N, et al. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 2002;105:2893-8.
40. Okamoto Y, Arita Y, Nishida M, et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res 2000;32:47-50.
41. Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation 1999;100:2473-6.
42. Wang Y, Lam KS, Xu JY, et al. Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerizationdependent manner. J Biol Chem 2005;280:18341-7.